Medicines (MDCO)
Add to Watchlists Create an Alert
32.99
-0.33 -0.99%
NASDAQ
May 24, 8:00PM
BATS Real time
Currency in USD
Medicines Net Income Quarterly:
-11.57M for Dec. 31, 2012Medicines Historical Net Income Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | -11.57M |
| Dec. 31, 2012 | 20.66M |
| Sept. 30, 2012 | 9.265M |
| June 30, 2012 | 13.76M |
| March 31, 2012 | 7.571M |
| Dec. 31, 2011 | 19.58M |
| Sept. 30, 2011 | 72.61M |
| June 30, 2011 | 11.44M |
| March 31, 2011 | 24.24M |
| Dec. 31, 2010 | 58.57M |
| Sept. 30, 2010 | 21.20M |
| June 30, 2010 | 15.43M |
| March 31, 2010 | 9.432M |
| Dec. 31, 2009 | -73.49M |
| Sept. 30, 2009 | -3.197M |
| June 30, 2009 | 3.811M |
| March 31, 2009 | -3.348M |
| Dec. 31, 2008 | -4.197M |
| Sept. 30, 2008 | -13.22M |
| June 30, 2008 | 4.056M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Net Income
Net income is what remains of a company's revenue after subtracting all costs. It is also referred to as net profit, earnings, or the bottom line. Net Income that is not paid out in dividends is added to retained earnings.
Increasing (decreasing) net income is a good (bad) sign for a company's profitability. Companies with consistent and increasing net income over time are looked at very favorably by stockholders.
Learn More
MDCO Net Income Quarterly Benchmarks
| Companies | |
|---|---|
| Ligand Pharmaceuticals | 1.495M |
| Bristol-Myers Squibb | 609.00M |
| Actavis | -102.80M |
MDCO Net Income Quarterly Rankings
| Overall |
33rd percentile 5083 of 7600 |
| Sector |
14th percentile 561 of 653 in Healthcare |
| Industry |
21st percentile 52 of 66 in Drug Manufacturers - Specialty & Generic |
MDCO Net Income Quarterly Range, Past 5 Years
| Minimum | -73.49M | Dec 2009 |
| Maximum | 72.61M | Sep 2011 |
| Average | 9.130M |